On December 11 in Hanoi, the Agency of Health Examination and Treatment Administration (Ministry of Health) coordinated with UNDP, KOFIH,... Read more
Category: Uncategorized
Administrative News: Thanh Hóa Appoints New Leadership for Department of Health
On the morning of December 12, the Thanh Hóa Provincial Department of Health held a conference to announce the Provincial... Read more
Scientific Bulletin: New Approach in Heart Failure Treatment
The 2nd National Scientific Conference on Heart Failure, held in Ho Chi Minh City on December 13, focused on the... Read more
Pharmaceutical Corporation Breaks Ground on Flagship US Production Center in North Carolina
EAST HANOVER, December 12, 2025 – The global pharmaceutical corporation Novartis has commenced construction on its major strategic manufacturing center... Read more
Zydus Lifesciences and Formycon Partner to Supply Keytruda® Biosimilar for Cancer Patients in US and Canada
Zydus Lifesciences (India) and Formycon AG (Germany) have entered into an exclusive strategic partnership to license and supply FYB206, a... Read more
Novartis and UK Biotech Relation Announce R&D Collaboration
Novartis, the major pharmaceutical corporation, has signed a multi-program research and development partnership agreement with Relation Therapeutics, an AI-driven biotech... Read more
Moderna Partners with Nanexa to Extend Injectable Drug Efficacy
Moderna, the mRNA specialist, has entered a licensing agreement with Nanexa, a Swedish biotech company, to incorporate tailored release profiles... Read more
Pfizer Continues Global Restructuring, Hundreds of Swiss Employees Affected by Layoffs
Pharmaceutical giant Pfizer is expanding its global cost-cutting agenda, with reports indicating that hundreds of employees in Switzerland are set... Read more
Geron Pharmaceutical Corporation Implements Second Round of Workforce Reduction
Geron Corporation, the pharmaceutical company based in Foster City, California, has disclosed a substantial restructuring plan that will involve laying... Read more









